News

Researchers have discovered how to improve the anti-tumour power of CAR T cells, artificial immune ‘‘super cells’’ used against blood cancers.

Scientists hoping to make bio-based manufacturing more renewable and carbon-neutral have developed a new workflow that combines CRISPR gene editing and computational models of microbial gene expression and enzyme activity.

The third Phase 1 clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the University of Oxford’s Pandemic Sciences Institute, has launched.

The Phase 1 trial of a new investigational universal flu vaccine has begun, which will evaluate the vaccine's safety and immunogenicity.

A natural compound in many plants has been found to inhibit the growth of drug-resistant Candida fungi, including the most virulent species.

Lung-resident memory cells are critical for pulmonary immunity. The pathway by which they develop following influenza infection has now been identified.

Researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.

Polycystic ovarian syndrome (PCOS) affects millions of women and is notoriously difficult to treat. A new treatment has been unveiled that may improve multiple PCOS symptoms.

For the first time, researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients’ own lung cells.

A new clinical trial will test the effects of ketone ester supplementation on frailty. The trial, funded by the National Institutes of Health, is called TAKEOFF and will recruit 180 participants.